Aspect Biosystems
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
143 employees · est. 2013 · Canada
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune diseases - Cartesian
4 employees · est. 2016
Aspect Biosystems is the older company (2013 vs 2016); Aspect Biosystems is the larger of the two.
Side-by-Side Comparison
| Metric | Aspect Biosystems | Cartesian Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2016 |
| Headquarters | ||
| Headquarters | Canada | Not tracked yet |
| Employees | ||
| Employees | 143 larger | 4 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biotechnology |
| Funding Stage | ||
| Funding Stage | Unknown | IPO |
| Total Funding | ||
| Total Funding | $323.73M | $132.00M |
| Funding Rounds | ||
| Funding Rounds | 15 | 4 |
| Services | ||
| Services | Development of Bioprinted Tissue Therapeutics, Regenerative Medicine Solutions, Cutting-edge Biotech Collaborations | Development of mRNA cell therapies, Clinical trials for autoimmune disease treatments, Biopharmaceutical innovation |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers focused on Metabolic and Endocrine Conditions, Research Institutions seeking advanced tissue therapies | Patients with autoimmune diseases, Healthcare providers, Medical institutions, Investors in biotech |
| Taxonomy | ||
| Taxonomy | Bioprinted Tissue Therapeutics, Cellular Medicines, Regenerative Medicine, AI-Powered Bioprinting, Hypoimmune Cell Engineering, Advanced Biomaterials, Endocrine Diseases, Metabolic Disorders, 3D Bioprinting Technology, Allogeneic Cell Therapy, Organ Function Restoration, Rare Endocrine Disorders, Diabetes Treatment, Tissue Therapeutic Platform, Partnerships In Biotech | Biopharmaceutical Company, Clinical-stage, Cell Therapies, Gene Therapies, Immunotherapy, Cancer Treatment, Autoimmune Disease Treatment, Respiratory Disease Treatment, CGMP Manufacturing, Biotechnology Sector, Novel Therapies, Therapeutic Development, Advanced Therapeutic Options, Clinical Operations |
| Website | ||
| Website | aspectbiosystems.com | cartesiantherapeutics.com |
About Aspect Biosystems
Aspect Biosystems is a pioneering force in the biotechnology landscape, focusing on bioprinted tissue therapeutics that promise to transform treatments for particularly elusive diseases. Their full-stack tissue therapeutic platform leverages proprietary AI-powered bioprinting technology, therapeutic...
About Cartesian Therapeutics
Cartesian Therapeutics is a cutting-edge, clinical-stage biopharmaceutical company that has carved a niche in the biotechnology sector since its founding in 2016. The company specializes in creating innovative cell and gene immunotherapies targeting a range of conditions such as cancer, autoimmune d...
We will tell you when either one moves
BounceWatch watches Aspect Biosystems and Cartesian Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aspect Biosystems and Cartesian Therapeutics — by email.
Frequently Asked Questions
Compare Aspect Biosystems with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Aspect Biosystems on 15 Jun 2026, and Cartesian Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.